— Shares gained more than 4% after the pharmaceutical company beat earnings expectations and reaffirmed full-year guidance, helping investors overlook underwhelming revenue. Viatris posted $932.
9 million in adjusted net income for the first quarter, beating the consensus estimate of $835.8 million from analysts polled by FactSet. But revenue came in at $3.72 billion, falling short of the $3.8 billion forecast from Wall Street.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: CNBC - 🏆 12. / 72 Прочитайте больше »